risankizumab
abbvie
['risan', 'keepsake 2', ' psa', 'keepsake 1']
#spa posters #acr22 2145. efficacy and safety of risankizumab for active psa 100-week results from keepsake 1 &amp; keepsake 2 durable efficacy response in psa through 100 weeks rzb generally well tolerated, and there were new safety signals #acrambassador 
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books